Flexible gene panels are essential for personalised genetic testing

Size: px
Start display at page:

Download "Flexible gene panels are essential for personalised genetic testing"

Transcription

1 Flexible gene panels are essential for personalised genetic testing Stephen Abbs East Anglian Medical Genetics Service Cambridge University Hospitals NHS Foundation Trust

2 Clinical exome sequencing GEMINI clinical exome sequencing Introduced for routine testing, Feb 2014 Over 2600 diagnostic tests performed

3 Ability to test for large number of conditions - patient equity Flexible and responsive to clinical referrals Tests are visible and accessible Affordable High quality Requirements and advantages of clinical exome sequencing

4 GEMINI - CE Genomic Medicine Innovative Initiative Clinical Exome Illumina TruSight One sequencing panel Targets 4,813 clinically relevant genes NextSeq (36) / MiSeq (3) Coming September - TruSight One Expanded 1924 new genes Improvements to poorly performing regions

5 Diagnostic request Gene(s) sequenced and cost effective? Yes No Virtual gene panel(s) selected or established with referring/local consultants Alternative tests Clinical exome sequenced Data filtered for variants in virtual panel(s) Interpret variants, confirm pathogenic mutations Report

6 Number of virtual gene panels

7 Flexible gene/panel selection Referrals have been analysed for: Single gene panel (261 panels established) Single gene (88 genes) Multiple panels (2-8 panels; mean 2.5) Multiple genes (2-7 genes; mean 1.7) Panel(s) + gene(s) (1-12 panels; mean 1.7; 1-10 genes; mean 1.8)

8 Gene/panel selection 2663 referrals multiple panels 10.1% multiple genes 1.7% panel(s) + gene(s) 3.2% single gene 3.3% single panel 81.7%

9 Gene/panel selection 2663 referrals Combination of panels / genes 15%

10 Now 21% of referrals are for combinations of panels/genes % of referrals N=1091 N= N=

11 Example cases demonstrating flexibility of exomes

12 Example 1 9 year old with congenital ataxia and developmental delay Maternally inherited 918 kb heterozygous del 8q12.1 Carbonic anhydrase VIII, CA8 gene in deleted region - rare autosomal condition Cerebellar ataxia, mental retardation and disequilibrium syndrome 3, CAMRQ3 CA8: c.182a>g p.(try61cys) hemizygous variant, likely pathogenic

13 Example 2 2 year old with complex phenotype. Tested initially for septo-optic dysplasia (PAX6, HESX1). Mother met mother of a child with genitopatellar syndrome via SWAN, KAT6B mutation detected by DDD. Thought both children had same condition. Re-analysis of data detected de novo heterozygous likely pathogenic variant KAT6B: c.3893_3894insa p.(thr1300asnfs)

14 Example 3 6 month old with infantile spasms, microcephaly, lissencephaly, oculomotor apraxia, developmental delay. initially tested for epileptic encephalopathy panels. MRI result indicated further testing DCX, ACTB, ACTG1, DYNC1H1, RELN, TUBA1A, VLDLR, (KIF2A, TUBG1). Re-analysis of data detected heterozygous likely pathogenic variant TUBA1A: c.1186g>a p.(asp396thr). Consistent with phenotype

15 Flexibility of exomes Non-standard patient pathways eg 1. genes within deleted region 2. new phenotypic indications 3. new diagnostic test results Complex / heterogeneous clinical presentations requiring bespoke combination of tests

16 Improving access to genetic tests via exome sequencing Concept of exome sequencing is complex; referrals changed as clinicians gained experience Requirements: Readily accessible, up to date information about available tests Details of genes, panels, and approach to exome sequencing

17 clinical genetic test ordering platform established Doctors Online platform for ordering reliable tests from accredited labs Laboratories Searchable test catalogue Designed for genomics and Next Generation Sequencing Secure online payment Detailed quality metrics

18 Benefits of GeneAdviser platfom Tests readily found by gene, disease, laboratory Designed for displaying genomic sequencing panels Overlap between gene panels visible, useful for heterogeneous disorders Up to date information via API with lab s database Electronic ordering will reduce transcription between systems Simplified invoicing and payment Fast, secure delivery of reports to clinicians Just like Amazon!

19 Clinical exome sequencing Summary Ability to test for large number of conditions, ensuring patient equity Test requests have changed as clinicians become more familiar with exome testing Flexible panel design is essential to allow appropriate testing for individual phenotypes (21% of referrals) - personalised medicine Genes and panels visible and readily accessible via GeneAdviser

20 Acknowledgements Laboratory: Howard Martin, Fay Rodger, Jaycen Parr, Gillian Flavell Bioinformatics: Kim Brugger, Matt Garner, Dilna Pushpajan Database: Ian Johnson Data analysis & reporting: Olivera Spasic-Boskovic, Phil Twiss, Isabelle Delon, James Drummond, Ed Thompson, Namir Al-Hasso, Sarah Spiden, Julie Evans, Nick Gleadall, Sally Halsall, Harjeet Rai, Terence Elsey Patient referral: Numerous Clinical Geneticists around UK, Ruth Armstrong, Ramsay Bowden, Richard Sandford, Eamonn Maher et al GeneAdviser: Jelena Aleksic, Robert Stojnic

Rapid testing and prenatal diagnosis for at-risk couples presenting during pregnancy without a diagnosis

Rapid testing and prenatal diagnosis for at-risk couples presenting during pregnancy without a diagnosis Rapid testing and prenatal diagnosis for at-risk couples presenting during pregnancy without a diagnosis Stephen Abbs East Anglian Medical Genetics Service Cambridge University Hospitals NHS Foundation

More information

NGS in neurodegenerative disorders - our experience

NGS in neurodegenerative disorders - our experience Neurology Clinic, Clinical Center of Serbia Faculty of Medicine, University of Belgrade Belgrade, Serbia NGS in neurodegenerative disorders - our experience Marija Branković, MSc Belgrade, 2018 Next Generation

More information

CentoXome FUTURE'S KNOWLEDGE APPLIED TODAY

CentoXome FUTURE'S KNOWLEDGE APPLIED TODAY CentoXome FUTURE'S KNOWLEDGE APPLIED TODAY More genetic information requires cutting-edge interpretation techniques Whole Exome Sequencing For certain patients the combination of symptoms does not allow

More information

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier Test Disease Population Triad Disease name Epileptic encephalopathy, early infantile 4. OMIM number for disease 612164 Disease

More information

variant led to a premature stop codon p.k316* which resulted in nonsense-mediated mrna decay. Although the exact function of the C19L1 is still

variant led to a premature stop codon p.k316* which resulted in nonsense-mediated mrna decay. Although the exact function of the C19L1 is still 157 Neurological disorders primarily affect and impair the functioning of the brain and/or neurological system. Structural, electrical or metabolic abnormalities in the brain or neurological system can

More information

Cerebral Malformation gene panel

Cerebral Malformation gene panel Cerebral Malformation gene panel Dr John Livingston Consultant Paediatric Neurologist Leeds Teaching Hospitals NHS Trust on behalf of Yorkshire Regional Genetics Service Leeds UK Cerebral Malformation

More information

CURRENT GENETIC TESTING TOOLS IN NEONATAL MEDICINE. Dr. Bahar Naghavi

CURRENT GENETIC TESTING TOOLS IN NEONATAL MEDICINE. Dr. Bahar Naghavi 2 CURRENT GENETIC TESTING TOOLS IN NEONATAL MEDICINE Dr. Bahar Naghavi Assistant professor of Basic Science Department, Shahid Beheshti University of Medical Sciences, Tehran,Iran 3 Introduction Over 4000

More information

CentoXome FUTURE'S KNOWLEDGE APPLIED TODAY

CentoXome FUTURE'S KNOWLEDGE APPLIED TODAY CentoXome FUTURE'S KNOWLEDGE APPLIED TODAY More genetic information requires cutting-edge interpretation techniques Whole Exome Sequencing For some patients, the combination of symptoms does not allow

More information

The Deciphering Development Disorders (DDD) project: What a genomic approach can achieve

The Deciphering Development Disorders (DDD) project: What a genomic approach can achieve The Deciphering Development Disorders (DDD) project: What a genomic approach can achieve RCP ADVANCED MEDICINE, LONDON FEB 5 TH 2018 HELEN FIRTH DM FRCP DCH, SANGER INSTITUTE 3,000,000,000 bases in each

More information

Assessing Laboratory Performance for Next Generation Sequencing Based Detection of Germline Variants through Proficiency Testing

Assessing Laboratory Performance for Next Generation Sequencing Based Detection of Germline Variants through Proficiency Testing Assessing Laboratory Performance for Next Generation Sequencing Based Detection of Germline Variants through Proficiency Testing Karl V. Voelkerding, MD Professor of Pathology University of Utah Medical

More information

Deciphering Developmental Disorders (DDD) DDG2P

Deciphering Developmental Disorders (DDD) DDG2P Deciphering Developmental Disorders (DDD) DDG2P David FitzPatrick MRC Human Genetics Unit, University of Edinburgh Deciphering Developmental Disorders objectives research understand genetics of DD translation

More information

Genetic Counselling in relation to genetic testing

Genetic Counselling in relation to genetic testing Genetic Counselling in relation to genetic testing Dr Julie Vogt Consultant Geneticist West Midlands Regional Genetics Service September 2016 Disclosures for Research Support/P.I. Employee Consultant Major

More information

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier Test Disease Population Triad Disease name and description (please provide any alternative names you wish listed) (A)-Testing

More information

Movement Disorders Requisition Form

Movement Disorders Requisition Form Movement Disorders Requisition Form The University of Chicago Genetic Services Laboratories 5841 South Maryland Avenue, Room G701/MC0077, Chicago, IL 60637 Toll Free: 888.824.3637 Local: 773.834.0555 Fax:

More information

Practical challenges that copy number variation and whole genome sequencing create for genetic diagnostic labs

Practical challenges that copy number variation and whole genome sequencing create for genetic diagnostic labs Practical challenges that copy number variation and whole genome sequencing create for genetic diagnostic labs Joris Vermeesch, Center for Human Genetics K.U.Leuven, Belgium ESHG June 11, 2010 When and

More information

NGS Types of gene dossier applications UKGTN can evaluate

NGS Types of gene dossier applications UKGTN can evaluate NGS Types of gene dossier applications UKGTN can evaluate Jo Whittaker on behalf of the Genetic Test Evaluation Working Group & UKGTN Project team NGS used in a number of ways Replacement technology for

More information

AVENIO ctdna Analysis Kits The complete NGS liquid biopsy solution EMPOWER YOUR LAB

AVENIO ctdna Analysis Kits The complete NGS liquid biopsy solution EMPOWER YOUR LAB Analysis Kits The complete NGS liquid biopsy solution EMPOWER YOUR LAB Analysis Kits Next-generation performance in liquid biopsies 2 Accelerating clinical research From liquid biopsy to next-generation

More information

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier/Additional Provider

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier/Additional Provider Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier/Additional Provider TEST DISEASE/CONDITION POPULATION TRIAD Submitting laboratory: Manchester RGC Approved: September 2013

More information

Heartland Genetics and Newborn Screening Collaborative Conference

Heartland Genetics and Newborn Screening Collaborative Conference Heartland Genetics and Newborn Screening Collaborative Conference Laurel K. Willig, MD Assistant Medical Director for the Center for Pediatric Genomic Medicine and Joshua E. Petrikin, MD Director of Neonatal

More information

Whole exome sequencing as a first line test: Is there even a role for metabolic biochemists in the future?

Whole exome sequencing as a first line test: Is there even a role for metabolic biochemists in the future? Whole exome sequencing as a first line test: Is there even a role for metabolic biochemists in the future? Tony Marinakii Purine Research Laboratory Biochemical Sciences Whole exome sequencing No doubt

More information

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier/Additional Provider

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier/Additional Provider Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier/Additional Provider TEST DISORDER/CONDITION POPULATION TRIAD Submitting laboratory: Exeter RGC Approved: Sept 2013 1. Disorder/condition

More information

Implementation of the DDD/ClinGen OGT (CytoSure v3) Microarray

Implementation of the DDD/ClinGen OGT (CytoSure v3) Microarray Implementation of the DDD/ClinGen OGT (CytoSure v3) Microarray OGT UGM Birmingham 08/09/2016 Dom McMullan Birmingham Women's NHS Trust WM chromosomal microarray (CMA) testing Population of ~6 million (10%)

More information

Clinical utility of the functional mrna evaluation of rare genetic variants in diagnostic practice

Clinical utility of the functional mrna evaluation of rare genetic variants in diagnostic practice Clinical utility of the functional mrna evaluation of rare genetic variants in diagnostic practice Celia Duff-Farrier: STP MSc project 2017 Funding provided by the Showering Fund mrna functional evaluation

More information

Improving genomic diagnoses through accurate, specific phenotype information

Improving genomic diagnoses through accurate, specific phenotype information Improving genomic diagnoses through accurate, specific phenotype information Lisa Ewans Clinical Geneticist, RPAH, Sydney PhD student in genomics, KCCG, Garvan; UNSW https://vlab.org Overview Phenotype

More information

AVENIO family of NGS oncology assays ctdna and Tumor Tissue Analysis Kits

AVENIO family of NGS oncology assays ctdna and Tumor Tissue Analysis Kits AVENIO family of NGS oncology assays ctdna and Tumor Tissue Analysis Kits Accelerating clinical research Next-generation sequencing (NGS) has the ability to interrogate many different genes and detect

More information

Benefits and pitfalls of new genetic tests

Benefits and pitfalls of new genetic tests Benefits and pitfalls of new genetic tests Amanda Krause Division of Human Genetics, NHLS and University of the Witwatersrand Definition of Genetic Testing the analysis of human DNA, RNA, chromosomes,

More information

Rare Disease Research and the UK 100,000 Genome Project

Rare Disease Research and the UK 100,000 Genome Project Rare Disease Research and the UK 100,000 Genome Project Prof F Lucy Raymond MA DPhil FRCP Department of Medical Genetics University of Cambridge UK Flr24@cam.ac.uk Copenhagen October Precision Medicine

More information

100,000 genomes RD Validation and Reporting Working Groups - Overview - Dom McMullan Chair Association for Clinical Genomic Science

100,000 genomes RD Validation and Reporting Working Groups - Overview - Dom McMullan Chair Association for Clinical Genomic Science 100,000 genomes RD Validation and Reporting Working Groups - Overview - Dom McMullan Chair Association for Clinical Genomic Science What? More Working Groups? Post January 20 th meeting Volunteers for

More information

TECHNOLOGICAL OPPORTUNITIES AND

TECHNOLOGICAL OPPORTUNITIES AND TECHNOLOGICAL OPPORTUNITIES AND INNOVATIONS TO IMPROVE EPILEPSY DIAGNOSIS AND MANAGEMENT THE ROLE OF SMES European Forum on Epilepsy Research Dublin 2013 Emmanuel Martin Director Genomics Services 1 Operations

More information

Next Generation Children. Association for Clinical Genetic Science meeting 27th June 2017 Alba Sanchis Juan,

Next Generation Children. Association for Clinical Genetic Science meeting 27th June 2017 Alba Sanchis Juan, Next Generation Children Association for Clinical Genetic Science meeting 27th June 2017 Alba Sanchis Juan, as2635@cam.ac.uk NGC project Genetic testing for patients from NICU and PICU with a suspected

More information

Merging single gene-level CNV with sequence variant interpretation following the ACMGG/AMP sequence variant guidelines

Merging single gene-level CNV with sequence variant interpretation following the ACMGG/AMP sequence variant guidelines Merging single gene-level CNV with sequence variant interpretation following the ACMGG/AMP sequence variant guidelines Tracy Brandt, Ph.D., FACMG Disclosure I am an employee of GeneDx, Inc., a wholly-owned

More information

Your Health Topic : Genomics and Clinical Practice How genetics is improving care for patients

Your Health Topic : Genomics and Clinical Practice How genetics is improving care for patients Your Health Topic : Genomics and Clinical Practice How genetics is improving care for patients Speaker Dr Kevin Monahan FRCP PhD Consultant Gastroenterologist, Family History of Bowel Cancer Clinic, Chelsea

More information

Talking Genomes with Your Patients. Meagan Cochran, MS, CGC Certified Genetic Counselor HudsonAlpha Institute for Biotechnology

Talking Genomes with Your Patients. Meagan Cochran, MS, CGC Certified Genetic Counselor HudsonAlpha Institute for Biotechnology Talking Genomes with Your Patients Meagan Cochran, MS, CGC Certified Genetic Counselor HudsonAlpha Institute for Biotechnology Objectives Review the importance of physician familiarity with genomic testing

More information

Multiple Copy Number Variations in a Patient with Developmental Delay ASCLS- March 31, 2016

Multiple Copy Number Variations in a Patient with Developmental Delay ASCLS- March 31, 2016 Multiple Copy Number Variations in a Patient with Developmental Delay ASCLS- March 31, 2016 Marwan Tayeh, PhD, FACMG Director, MMGL Molecular Genetics Assistant Professor of Pediatrics Department of Pediatrics

More information

Genetics and Genomics: Applications to Developmental Disability

Genetics and Genomics: Applications to Developmental Disability Tuesday, 12:30 2:00, B1 Objective: Genetics and Genomics: Applications to Developmental Disability Helga Toriello 616-234-2712 toriello@msu.edu Identify advances in clinical assessment and management of

More information

Golden Helix s End-to-End Solution for Clinical Labs

Golden Helix s End-to-End Solution for Clinical Labs Golden Helix s End-to-End Solution for Clinical Labs Steven Hystad - Field Application Scientist Nathan Fortier Senior Software Engineer 20 most promising Biotech Technology Providers Top 10 Analytics

More information

Intellectual Disability Exome Panel Requisition Form

Intellectual Disability Exome Panel Requisition Form Intellectual Disability Exome Panel Requisition Form The University of Chicago Genetic Services Laboratories 5841 South Maryland Avenue, Room G701/MC0077, Chicago, IL 60637 Toll Free: 888.824.3637 Local:

More information

Test Information Sheet

Test Information Sheet Prenatal Lissencephaly Panel Sequence Analysis and Exon-Level Deletion/Duplication Testing* of 24 Genes Panel Gene List: ACTB, ACTG1, X, ATP6V0A2, B3GALNT2*, B4GAT1*, DCX, FKRP*, FKTN, GMPPB*, ISPD, LAMB1,

More information

The Focused Exome service at Bristol Genetics Laboratory

The Focused Exome service at Bristol Genetics Laboratory The Focused Exome service at Bristol Genetics Laboratory Chris Buxton Maggie Williams July 2016 Bristol Clinical exome Service to mid July Validation: Agilent FE kit, NextSeq 500 and new pipeline 1st reports

More information

NHS Array Service. ACC Audit 2009

NHS Array Service. ACC Audit 2009 NHS Array Service ACC Audit 2009 Kim Smith ACC Audit of arrays in diagnostics NHS Diagnostic Laboratories 2008 audit Regional Genetic Centres (24 centres) Specialist Haematological Cytogenetics Laboratories

More information

Personalis ACE Clinical Exome The First Test to Combine an Enhanced Clinical Exome with Genome- Scale Structural Variant Detection

Personalis ACE Clinical Exome The First Test to Combine an Enhanced Clinical Exome with Genome- Scale Structural Variant Detection Personalis ACE Clinical Exome The First Test to Combine an Enhanced Clinical Exome with Genome- Scale Structural Variant Detection Personalis, Inc. 1350 Willow Road, Suite 202, Menlo Park, California 94025

More information

Variant Detection & Interpretation in a diagnostic context. Christian Gilissen

Variant Detection & Interpretation in a diagnostic context. Christian Gilissen Variant Detection & Interpretation in a diagnostic context Christian Gilissen c.gilissen@gen.umcn.nl 28-05-2013 So far Sequencing Johan den Dunnen Marja Jakobs Ewart de Bruijn Mapping Victor Guryev Variant

More information

Genomics for Rare Diseases

Genomics for Rare Diseases Genomics for Rare Diseases Gemma Chandratillake & Karola Rehnström East of England NHS Genomic Medicine Centre 21 st March 2018 Overview The genetic basis of rare disease Why is it useful to know the genetic

More information

110 DISEASES 3 DISEASES GENE TIC COUNSELING CARRIERMAP Recombine. Others. 30+ minute clinical genetic counseling session.

110 DISEASES 3 DISEASES GENE TIC COUNSELING CARRIERMAP Recombine. Others. 30+ minute clinical genetic counseling session. Recombine CARRIERMAP GENE TIC COUNSELING Genetic diseases, though individually rare, are collectively common; thus, assessing carrier status is one of the most important things you can do for your patients.

More information

Genetics update and implications for (General) Practice

Genetics update and implications for (General) Practice Genetics update and implications for (General) Practice May 12 th 2018 Women s Health Symposium Clearwater Estate Dr Kate Gibson MB BCh, MRCP, FRACP Topics NZ Clinical Genetics delivery New Technologies

More information

Global variation in copy number in the human genome

Global variation in copy number in the human genome Global variation in copy number in the human genome Redon et. al. Nature 444:444-454 (2006) 12.03.2007 Tarmo Puurand Study 270 individuals (HapMap collection) Affymetrix 500K Whole Genome TilePath (WGTP)

More information

The 100,000 Genomes Project Harnessing the power of genomics for NHS rare disease and cancer patients

The 100,000 Genomes Project Harnessing the power of genomics for NHS rare disease and cancer patients The 100,000 Genomes Project Harnessing the power of genomics for NHS rare disease and cancer patients Dr Richard Scott, Clinical Lead for Rare Disease Dr Nirupa Murugaesu, Clinical Lead for Cancer Four

More information

RACP Congress 2017 Genetics of Intellectual Disability and Autism: Past Present and Future 9 th May 2017

RACP Congress 2017 Genetics of Intellectual Disability and Autism: Past Present and Future 9 th May 2017 RACP Congress 2017 Genetics of Intellectual Disability and Autism: Past Present and Future 9 th May 2017 Why causation? Explanation for family Prognosis Recurrence risk and reproductive options Guide medical

More information

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier Test Disease Population Triad Disease name Leber congenital amaurosis OMIM number for disease 204000 Disease alternative

More information

Challenges of CGH array testing in children with developmental delay. Dr Sally Davies 17 th September 2014

Challenges of CGH array testing in children with developmental delay. Dr Sally Davies 17 th September 2014 Challenges of CGH array testing in children with developmental delay Dr Sally Davies 17 th September 2014 CGH array What is CGH array? Understanding the test Benefits Results to expect Consent issues Ethical

More information

CHAPTER IV RESULTS Microcephaly General description

CHAPTER IV RESULTS Microcephaly General description 47 CHAPTER IV RESULTS 4.1. Microcephaly 4.1.1. General description This study found that from a previous study of 527 individuals with MR, 48 (23 female and 25 male) unrelated individuals were identified

More information

Approach to the Genetic Diagnosis of Neurological Disorders

Approach to the Genetic Diagnosis of Neurological Disorders Approach to the Genetic Diagnosis of Neurological Disorders Dr Wendy Jones MBBS MRCP Great Ormond Street Hospital for Children National Hospital for Neurology and Neurosurgery What is a genetic diagnosis?

More information

Riunione Regionale SIN Campania

Riunione Regionale SIN Campania Riunione Regionale SIN Campania Dott.ssa Maria Lieto Dipartimento di Neuroscienze, Università Federico II Napoli Salerno, 14 dicembre 2018 HEREDITARY ATAXIAS SCAs (35 genes) ARCAs (94 genes) Diagnosis?

More information

Genetics/Genomics: role of genes in diagnosis and/risk and in personalised medicine

Genetics/Genomics: role of genes in diagnosis and/risk and in personalised medicine Genetics/Genomics: role of genes in diagnosis and/risk and in personalised medicine Lynn Greenhalgh, Macmillan Cancer and General Clinical Geneticist Cancer Genetics Service Cancer is common 1 in

More information

The Patient Perspective: diagnostic Exome Sequencing

The Patient Perspective: diagnostic Exome Sequencing 1 2 Hello, I m Teresa Kruisselbrink, genetic counselor in the Center of Individualized Medicine. 3 I have nothing to disclose. 4 The title of my talk, The patient perspective; diagnostic whole exome sequencing,

More information

Concurrent Practical Session ACMG Classification

Concurrent Practical Session ACMG Classification Variant Effect Prediction Training Course 6-8 November 2017 Prague, Czech Republic Concurrent Practical Session ACMG Classification Andreas Laner / Anna Benet-Pagès 1 Content 1. Background... 3 2. Aim

More information

Approach to Mental Retardation and Developmental Delay. SR Ghaffari MSc MD PhD

Approach to Mental Retardation and Developmental Delay. SR Ghaffari MSc MD PhD Approach to Mental Retardation and Developmental Delay SR Ghaffari MSc MD PhD Introduction Objectives Definition of MR and DD Classification Epidemiology (prevalence, recurrence risk, ) Etiology Importance

More information

Evolution of Genetic Testing. Joan Pellegrino MD Associate Professor of Pediatrics SUNY Upstate Medical University

Evolution of Genetic Testing. Joan Pellegrino MD Associate Professor of Pediatrics SUNY Upstate Medical University Evolution of Genetic Testing Joan Pellegrino MD Associate Professor of Pediatrics SUNY Upstate Medical University Genetic Testing Chromosomal analysis Flourescent in situ hybridization (FISH) Chromosome

More information

West Midlands Familial Hypercholesterolaemia Service

West Midlands Familial Hypercholesterolaemia Service Elaine George WMFHS Clinical Programme Manager West Midlands Familial Hypercholesterolaemia Service Elaine George WMFHS Clinical Programme Manager PCCS Conference November 2018 1 Presentation Objectives

More information

Lab Activity Report: Mendelian Genetics - Genetic Disorders

Lab Activity Report: Mendelian Genetics - Genetic Disorders Name Date Period Lab Activity Report: Mendelian Genetics - Genetic Disorders Background: Sometimes genetic disorders are caused by mutations to normal genes. When the mutation has been in the population

More information

GENDER James Bier

GENDER James Bier GENDER 2005-2008 James Bier Objectives 1. State the method of determining gender in several genetic systems. 2. List the three regions of the Y chromosome. 3. Describe the events that promote sexual development

More information

CHROMOSOMAL MICROARRAY (CGH+SNP)

CHROMOSOMAL MICROARRAY (CGH+SNP) Chromosome imbalances are a significant cause of developmental delay, mental retardation, autism spectrum disorders, dysmorphic features and/or birth defects. The imbalance of genetic material may be due

More information

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier Test Disease Population Triad Disease name and description (please provide any alternative names you wish listed) (A)-Testing

More information

Copy Number Variants of Uncertain Significance in Prenatal diagnosis Are the Goalposts Moving? Lisa Burvill-Holmes Bristol Genetics Laboratory

Copy Number Variants of Uncertain Significance in Prenatal diagnosis Are the Goalposts Moving? Lisa Burvill-Holmes Bristol Genetics Laboratory Copy Number Variants of Uncertain Significance in Prenatal diagnosis Are the Goalposts Moving? Lisa Burvill-Holmes Bristol Genetics Laboratory http://www.nbt.nhs.uk/genetics Microarray CGH in Prenatal

More information

Using large-scale human genetic variation to inform variant prioritization in neuropsychiatric disorders

Using large-scale human genetic variation to inform variant prioritization in neuropsychiatric disorders Using large-scale human genetic variation to inform variant prioritization in neuropsychiatric disorders Kaitlin E. Samocha Hurles lab, Wellcome Trust Sanger Institute ACGS Summer Scientific Meeting 27

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy Invasive Prenatal (Fetal) Diagnostic Testing File Name: Origination: Last CAP Review: Next CAP Review: Last Review: invasive_prenatal_(fetal)_diagnostic_testing 12/2014 3/2018

More information

PERSONALIZED GENETIC REPORT CLIENT-REPORTED DATA PURPOSE OF THE X-SCREEN TEST

PERSONALIZED GENETIC REPORT CLIENT-REPORTED DATA PURPOSE OF THE X-SCREEN TEST INCLUDED IN THIS REPORT: REVIEW OF YOUR GENETIC INFORMATION RELEVANT TO ENDOMETRIOSIS PERSONAL EDUCATIONAL INFORMATION RELEVANT TO YOUR GENES INFORMATION FOR OBTAINING YOUR ENTIRE X-SCREEN DATA FILE PERSONALIZED

More information

NGS panels in clinical diagnostics: Utrecht experience. Van Gijn ME PhD Genome Diagnostics UMCUtrecht

NGS panels in clinical diagnostics: Utrecht experience. Van Gijn ME PhD Genome Diagnostics UMCUtrecht NGS panels in clinical diagnostics: Utrecht experience Van Gijn ME PhD Genome Diagnostics UMCUtrecht 93 Gene panels UMC Utrecht Cardiovascular disease (CAR) (5 panels) Epilepsy (EPI) (11 panels) Hereditary

More information

JULY 21, Genetics 101: SCN1A. Katie Angione, MS CGC Certified Genetic Counselor CHCO Neurology

JULY 21, Genetics 101: SCN1A. Katie Angione, MS CGC Certified Genetic Counselor CHCO Neurology JULY 21, 2018 Genetics 101: SCN1A Katie Angione, MS CGC Certified Genetic Counselor CHCO Neurology Disclosures: I have no financial interests or relationships to disclose. Objectives 1. Review genetic

More information

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier Test Disease Population Triad Disease name Genetic Causes of Hypothyroidism 1. Loss of function mutations in TSHR cause thyroid

More information

Interpretation can t happen in isolation. Jonathan S. Berg, MD/PhD Assistant Professor Department of Genetics UNC Chapel Hill

Interpretation can t happen in isolation. Jonathan S. Berg, MD/PhD Assistant Professor Department of Genetics UNC Chapel Hill Interpretation can t happen in isolation Jonathan S. Berg, MD/PhD Assistant Professor Department of Genetics UNC Chapel Hill With the advent of genome-scale sequencing, variant interpretation is increasingly

More information

Dysmorphology And The Paediatric Eye. Jill Clayton-Smith Manchester Centre For Genomic Medicine

Dysmorphology And The Paediatric Eye. Jill Clayton-Smith Manchester Centre For Genomic Medicine Dysmorphology And The Paediatric Eye Jill Clayton-Smith Manchester Centre For Genomic Medicine Why Make A Syndrome Diagnosis? Why did it happen? What does the future hold? How can you treat/manage it?

More information

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier Test Disease Population Triad Disease name Parkinson disease 8, automsomal dominant OMIM number for disease 607060 Disease

More information

Mainstreaming Cancer Genetics (MCG) Information Pack

Mainstreaming Cancer Genetics (MCG) Information Pack Mainstreaming Cancer Genetics (MCG) Key Points Information Pack Genetic information is important for people with cancer and their relatives. New gene testing methods can be harnessed so that more genes

More information

panel tests assessing multiple genes at the same time for the diagnosis of one or more related disorders

panel tests assessing multiple genes at the same time for the diagnosis of one or more related disorders NGS tests panel tests assessing multiple genes at the same time for the diagnosis of one or more related disorders UKGTN website lists 13 laboratories offering a total of 56 panel test UKGTN listed panel

More information

GENETIC MANAGEMENT OF A FAMILY HISTORY OF FAP or MUTYH ASSOCIATED POLYPOSIS. Family Health Clinical Genetics. Clinical Genetics department

GENETIC MANAGEMENT OF A FAMILY HISTORY OF FAP or MUTYH ASSOCIATED POLYPOSIS. Family Health Clinical Genetics. Clinical Genetics department GENETIC MANAGEMENT OF A FAMILY HISTORY OF FAP or MUTYH ASSOCIATED POLYPOSIS Full Title of Guideline: Author (include email and role): Division & Speciality: GUIDELINES FOR THE GENETIC MANAGEMENT OF A FAMILY

More information

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier Submitting laboratory: Bristol RGC 1. Disorder/condition approved name and symbol as published on the OMIM database (alternative

More information

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier Test Disease Population Triad Disease name OMIM number for disease 147920 Disease alternative names Please provide any alternative

More information

NHS Innovation Accelerator. Economic Impact Evaluation Case Study: Sapientia 1. BACKGROUND

NHS Innovation Accelerator. Economic Impact Evaluation Case Study: Sapientia 1. BACKGROUND NHS Innovation Accelerator Economic Impact Evaluation Case Study: Sapientia 1. BACKGROUND SAPIENTIA is a genome analytics software which enables the human genome to be interrogated to identify pathogenic

More information

The Power of the Participant Perspective. Julie Brinker, MPA Research Community Liaison Clinical Translation Research Center

The Power of the Participant Perspective. Julie Brinker, MPA Research Community Liaison Clinical Translation Research Center The Power of the Participant Perspective Julie Brinker, MPA Research Community Liaison Clinical Translation Research Center Objectives for this Presentation What is a research participant advisory group?

More information

MEDICAL GENOMICS LABORATORY. Next-Gen Sequencing and Deletion/Duplication Analysis of NF1 Only (NF1-NG)

MEDICAL GENOMICS LABORATORY. Next-Gen Sequencing and Deletion/Duplication Analysis of NF1 Only (NF1-NG) Next-Gen Sequencing and Deletion/Duplication Analysis of NF1 Only (NF1-NG) Ordering Information Acceptable specimen types: Fresh blood sample (3-6 ml EDTA; no time limitations associated with receipt)

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: genetic_testing_for_epilepsy 1/28/14 10/2017 10/2018 10/2017 Description of Procedure or Service Description

More information

BIOCHEMICAL AND MOLECULAR HETEROGENEITY IN CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY

BIOCHEMICAL AND MOLECULAR HETEROGENEITY IN CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY BIOCHEMICAL AND MOLECULAR HETEROGENEITY IN CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY Carmen Sousa, Helena Fonseca, Hugo Rocha, Ana Marcão, Laura Vilarinho, Luísa Diogo, Sílvia Sequeira, Cristina Costa,

More information

SETPEG GENETIC TESTING GUIDELINES Version 1.0, 5 th October 2017

SETPEG GENETIC TESTING GUIDELINES Version 1.0, 5 th October 2017 SETPEG GENETIC TESTING GUIDELINES Version 1.0, 5 th October 2017 1. The Epilepsy Genetic Diagnostic & Counselling Service at King s Health Partners Professor Deb Pal PhD MRCP (Consultant) deb.pal@nhs.net

More information

Personalised cancer care Information for Medical Specialists. A new way to unlock treatment options for your patients

Personalised cancer care Information for Medical Specialists. A new way to unlock treatment options for your patients Personalised cancer care Information for Medical Specialists A new way to unlock treatment options for your patients Contents Optimised for clinical benefit 4 Development history 4 Full FIND IT panel vs

More information

MNGenome Sequencing Test Request Form

MNGenome Sequencing Test Request Form MNGenome Sequencing Test Request Form Whole Whole Genome Exome Sequencing Note: Clinical Information and Consent Form are required for MNGenome Orders. *Please note if samples are shipping separately as

More information

What s the Human Genome Project Got to Do with Developmental Disabilities?

What s the Human Genome Project Got to Do with Developmental Disabilities? What s the Human Genome Project Got to Do with Developmental Disabilities? Disclosures Neither speaker has anything to disclose. Phase Two: Interpretation Officially started in October 1990 Goals of the

More information

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier Test Disease Population Triad Disease name Choroideremia OMIM number for disease 303100 Disease alternative names please

More information

Guide to Use of SimulConsult s Phenome Software

Guide to Use of SimulConsult s Phenome Software Guide to Use of SimulConsult s Phenome Software Page 1 of 52 Table of contents Welcome!... 4 Introduction to a few SimulConsult conventions... 5 Colors and their meaning... 5 Contextual links... 5 Contextual

More information

Exome Requisition Form

Exome Requisition Form Patient Information Exome Requisition Form The University of Chicago Genetic Services Laboratories 5841 South Maryland Avenue, Room G701/MC0077, Chicago, IL 60637 Toll Free: 888.824.3637 Local: 773.834.0555

More information

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier Test Disease Population Triad Disease name and description (please provide any alternative names you wish listed) (A)-Testing

More information

Genetic Testing and Analysis. (858) MRN: Specimen: Saliva Received: 07/26/2016 GENETIC ANALYSIS REPORT

Genetic Testing and Analysis. (858) MRN: Specimen: Saliva Received: 07/26/2016 GENETIC ANALYSIS REPORT GBinsight Sample Name: GB4411 Race: Gender: Female Reason for Testing: Type 2 diabetes, early onset MRN: 0123456789 Specimen: Saliva Received: 07/26/2016 Test ID: 113-1487118782-4 Test: Type 2 Diabetes

More information

Paediatrics and Neuro-development MIC Theme 7

Paediatrics and Neuro-development MIC Theme 7 Brain Injury MedTech Co-operative Paediatrics and Neuro-development MIC Theme 7 Professor David Rowitch & Professor Topun Austin The is a partnership between the Cambridge University Hospitals NHS Foundation

More information

Nature Genetics: doi: /ng Supplementary Figure 1

Nature Genetics: doi: /ng Supplementary Figure 1 Supplementary Figure 1 Illustrative example of ptdt using height The expected value of a child s polygenic risk score (PRS) for a trait is the average of maternal and paternal PRS values. For example,

More information

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier Test Disease Population Triad Disease name and description (please provide any alternative names Osteogenesis Imperfecta

More information

DNA-seq Bioinformatics Analysis: Copy Number Variation

DNA-seq Bioinformatics Analysis: Copy Number Variation DNA-seq Bioinformatics Analysis: Copy Number Variation Elodie Girard elodie.girard@curie.fr U900 institut Curie, INSERM, Mines ParisTech, PSL Research University Paris, France NGS Applications 5C HiC DNA-seq

More information

Exploding Genetic Knowledge in Developmental Disabilities. Disclosures. The Genetic Principle

Exploding Genetic Knowledge in Developmental Disabilities. Disclosures. The Genetic Principle Exploding Genetic Knowledge in Developmental Disabilities How to acquire the data and how to make use of it Elliott H. Sherr MD PhD Professor of Neurology & Pediatrics UCSF Disclosures InVitae: clinical

More information

Pondering Epilepsy Classification (actually a few thoughts on the impact of genetic analyses of the epilepsies) Genetics of Epilepsies

Pondering Epilepsy Classification (actually a few thoughts on the impact of genetic analyses of the epilepsies) Genetics of Epilepsies Pondering Epilepsy Classification (actually a few thoughts on the impact of genetic analyses of the epilepsies) Dan Lowenstein UCSF Department of Neurology and the UCSF Epilepsy Center To Cover: 1. Update

More information

Van test naar diagnose naar

Van test naar diagnose naar Van test naar diagnose naar V therapie op maat Marjolein Kriek, LUMC Joris Veltman, RUNMC Exome diagnostics in genetically heterogeneous disease Joris Veltman, PhD Department of Human Genetics Radboud

More information

Identifying Mutations Responsible for Rare Disorders Using New Technologies

Identifying Mutations Responsible for Rare Disorders Using New Technologies Identifying Mutations Responsible for Rare Disorders Using New Technologies Jacek Majewski, Department of Human Genetics, McGill University, Montreal, QC Canada Mendelian Diseases Clear mode of inheritance

More information